Brief: Algernon To Support Planned Phase 2 Trial Of Ifenprodil For Coronavirus
19/03/2020 13:01
Algernon Pharmaceuticals Inc AGN.CD :
* ALGERNON TO SUPPORT PLANNED PHASE 2 TRIAL OF IFENPRODIL
FOR
CORONAVIRUS
Source text for Eikon: ID:nGNXbNv3jP
Further company coverage: AGN.CD
Recent news on Grey Matters Health
See all newsBrief: Grey Matters Announces The Closing Of Its Equity And Convertible Debenture Private Placement Totalling CAD $1.12 Million
Brief: Algernon Announces Additional Increase To Private Placement Financing
Brief: Algernon Health Announces Private Placement
Brief: Algernon Announces Closing Of The Private Placement Financing
Brief: Algernon Announces $1 Mln Private Placement